-
1 Comment
Shanghai Haixin Group Co., Ltd is currently in a long term uptrend where the price is trading 4.3% above its 200 day moving average.
From a valuation standpoint, the stock is 44.7% cheaper than other stocks from the Industrials sector with a price to sales ratio of 2.8.
Shanghai Haixin Group Co., Ltd's total revenue sank by 15.3% to $310M since the same quarter in the previous year.
Its net income has increased by 10.4% to $29M since the same quarter in the previous year.
Finally, its free cash flow grew by 117.5% to $20M since the same quarter in the previous year.
Based on the above factors, Shanghai Haixin Group Co., Ltd gets an overall score of 4/5.
| Exchange | SHG |
|---|---|
| CurrencyCode | USD |
| ISIN | CNE000000DX2 |
| Sector | Industrials |
| Industry | Conglomerates |
| Dividend Yield | 14.% |
|---|---|
| Market Cap | 867M |
| PE Ratio | 13.65 |
| Target Price | None |
| Beta | 0.63 |
Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics and clothing. The company was founded in 1986 and is headquartered in Shanghai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 900917.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
